| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |